Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living With HIV/AIDS (PLWHA) With Non-Infectious Diarrhea

NCT04192487 is registered in ClinicalTrials.gov with Napo Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04192487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04192487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living With HIV/AIDS (PLWHA) With Non-Infectious Diarrhea
Lead sponsor
Napo Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 22, 2019
Completion date
August 31, 2021
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, healthy volunteers, hiv diarrhea, hiv/aids, human immunodeficiency virus